Arca
Skip to content
Tools
Tools

FOLA: Dihydrofolate reductase

Protein in Bacteria that 3 drugs act on.

  • Drugs that act on it: 3
  • Approved: 1
  • In phases 1 to 3: 2
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on FOLA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3

Approved1

  • Trimethoprim

Phase 32

  • Co-trimoxazole
  • Iclaprim

Phase 20

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Bacterial dihydrofolate reductase inhibitor.
      TrimethoprimApprovedMerck & Co. (MSD)Small moleculeInhibitor57
      Co-trimoxazolePhase 3Merck & Co. (MSD)Small moleculeInhibitor55
      IclaprimPhase 3Arpida AGSmall moleculeInhibitor1

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 10 in all, from ClinicalTrials.gov.
      Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral Follow-up Treatment in Febrile Urinary Tract Infections in Men Caused by Susceptible EnterobacteriaCo-trimoxazolePhase 3Not yet recruitingAssistance Publique - Hôpitaux de ParisNov 12, 2026
      A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)Co-trimoxazole, TrimethoprimPhase 2 / Phase 3Not yet recruitingMerck Sharp & Dohme LLCNov 5, 2026
      Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeCo-trimoxazole, TrimethoprimPhase 3Not yet recruitingChildren's Hospital of Fudan UniversityAug 14, 2026
      TMP-SMX for Non-HIV PCP: A Prospective Multicenter StudyCo-trimoxazole, Trimethoprim—Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineJul 8, 2026
      Precision Management of Urinary Tract Symptoms in Older WomenCo-trimoxazole, TrimethoprimPhase 3RecruitingMegan BradleyJul 7, 2026
      Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPDCo-trimoxazole, TrimethoprimNot applicableNot yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineJun 24, 2026
      Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsCo-trimoxazole, TrimethoprimEarly phase 1RecruitingThe Cleveland ClinicJun 15, 2026
      Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney TransplantationCo-trimoxazole, TrimethoprimPhase 4Not yet recruitingAnhui Provincial HospitalJun 1, 2026
      Extended Oral Antibiotic Prophylaxis in Diabetic Fracture PatientsTrimethoprimPhase 4RecruitingTexas Tech University Health Sciences Center, El PasoMay 1, 2026
      Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate CancerIclaprimPhase 1 / Phase 2Active, not recruitingUniversity of Wisconsin, MadisonAug 4, 2021

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364669, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.